These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9748732)

  • 1. [Immunomodulation in the treatment of atopic dermatitis].
    Jílek D; Král V; Duchková H; Richter J
    Cas Lek Cesk; 1998 Jun; 137(13):397-9. PubMed ID: 9748732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic options in the treatment of psoriasis and atopic dermatitis.
    Gottlieb AB
    J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S3-16. PubMed ID: 15968262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Future perspectives in the treatment of atopic dermatitis.
    Katoh N
    J Dermatol; 2009 Jul; 36(7):367-76. PubMed ID: 19583684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent developments in the treatment of adult atopic dermatitis.
    Pua VS; Barnetson RS
    Australas J Dermatol; 2006 May; 47(2):84-9. PubMed ID: 16637800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of atopic dermatitis with a combination of allergen-specific immunotherapy and a histamine-immunoglobulin complex.
    Nahm DH; Lee ES; Park HJ; Kim HA; Choi GS; Jeon SY
    Int Arch Allergy Immunol; 2008; 146(3):235-40. PubMed ID: 18268392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic, prophylactic and therapeutic guidelines in patients with atopic dermatitis. Position paper by the task force of the National Specialists on Dermatology, Venereology and Allergology].
    Gliński W; Kruszewski J; Silny W; Kurzawa R; Czarnecka-Operacz M; Baran E; Szepietowski J;
    Pol Merkur Lekarski; 2004; 17 Suppl 3():3-15. PubMed ID: 15688665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atopic dermatitis: systemic immunosuppressive therapy.
    Akhavan A; Rudikoff D
    Semin Cutan Med Surg; 2008 Jun; 27(2):151-5. PubMed ID: 18620137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of immunostimulatory liposome-nucleic acid complexes in allergen-specific immunotherapy of dogs with refractory atopic dermatitis - a pilot study.
    Mueller RS; Veir J; Fieseler KV; Dow SW
    Vet Dermatol; 2005 Feb; 16(1):61-8. PubMed ID: 15725107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Selective phototherapy and immunocorrection with dimotsifon in atopic dermatitis].
    Potekaev NS; Sevidova LIu; Vladimirov VV; Kochergin NG; Shinaev NN
    Vestn Dermatol Venerol; 1987; (9):39-42. PubMed ID: 3424982
    [No Abstract]   [Full Text] [Related]  

  • 10. Comprehensive management of atopic dermatitis.
    Urash JJ; Bahna SL
    Compr Ther; 1996 Jul; 22(7):429-33. PubMed ID: 8866194
    [No Abstract]   [Full Text] [Related]  

  • 11. First experience with enteric-coated mycophenolate sodium (Myfortic) in severe recalcitrant adult atopic dermatitis: an open label study.
    van Velsen SG; Haeck IM; Bruijnzeel-Koomen CA; de Bruin-Weller MS
    Br J Dermatol; 2009 Mar; 160(3):687-91. PubMed ID: 19120337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of immunotherapy in myelitis with atopic diathesis.
    Murai H; Arahata H; Osoegawa M; Ochi H; Minohara M; Taniwaki T; Tobimatsu S; Mihara F; Tsuruta Y; Inaba S; Kira J
    J Neurol Sci; 2004 Dec; 227(1):39-47. PubMed ID: 15546590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Systemic therapy of atopic dermatitis].
    Heratizadeh A; Breuer K; Kapp A; Werfel T
    Hautarzt; 2003 Oct; 54(10):937-45. PubMed ID: 14513240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study.
    Bussmann C; Maintz L; Hart J; Allam JP; Vrtala S; Chen KW; Bieber T; Thomas WR; Valenta R; Zuberbier T; Sager A; Novak N
    Clin Exp Allergy; 2007 Sep; 37(9):1277-85. PubMed ID: 17845407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possibilities of immunomodulation in atopic dermatitis: a preliminary trial with broncho-vaxom.
    Czerniawska-Mysik G; Adamek-Guzik T; Prochowska-Mitka K
    Pneumonol Alergol Pol; 1992; 60 Suppl 2():113-6. PubMed ID: 1305485
    [No Abstract]   [Full Text] [Related]  

  • 16. Specific sublingual immunotherapy in atopic dermatitis. Results of a 6-year follow-up of 35 consecutive patients.
    Mastrandrea F; Serio G; Minelli M; Minardi A; Scarcia G; Coradduzza G; Parmiani S
    Allergol Immunopathol (Madr); 2000; 28(2):54-62. PubMed ID: 10804094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic therapeutic options for severe atopic dermatitis.
    BuBmann C; Bieber T; Novak N
    J Dtsch Dermatol Ges; 2009 Mar; 7(3):205-19. PubMed ID: 18759739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous immune globulin (i.v.IG) therapy in steroid-resistant atopic dermatitis.
    Noh G; Lee KY
    J Korean Med Sci; 1999 Feb; 14(1):63-8. PubMed ID: 10102526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of atopic dermatitis].
    Bakos N; Nékám K
    Orv Hetil; 2003 Aug; 144(34):1689-91. PubMed ID: 14528844
    [No Abstract]   [Full Text] [Related]  

  • 20. Quantitation of canine regulatory T cell populations, serum interleukin-10 and allergen-specific IgE concentrations in healthy control dogs and canine atopic dermatitis patients receiving allergen-specific immunotherapy.
    Keppel KE; Campbell KL; Zuckermann FA; Greeley EA; Schaeffer DJ; Husmann RJ
    Vet Immunol Immunopathol; 2008 Jun; 123(3-4):337-44. PubMed ID: 18423890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.